JACOB CASLOW: Open Payments
NPI 1700412418 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 93 payments from 22 companies in 2025. Trend: 2023 $1,369 · 2024 $1,615 · 2025 $1,527
Food & beverage: $1,527
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $462 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $222 |
| Phathom Pharmaceuticals, Inc. | 7 | $116 |
| Novo Nordisk Inc | 6 | $104 |
| Axsome Therapeutics, Inc. | 5 | $95 |
| Astellas Pharma US Inc | 4 | $84 |
| Verona Pharma, Inc. | 2 | $62 |
| Corcept Therapeutics | 3 | $47 |
| Exact Sciences Corporation | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
Products named: CAPLYTA, VRAYLAR, VOQUEZNA, CREON, MAVYRET, Wegovy, Veozah, Ohtuvayre.
Industry payments across OH — which companies pay providers there.
